Cryosphere Podcast Cryosphere Chat
13 snips
Sep 28, 2025 Eric Magro, involved in longevity initiatives, shares insights from the Longevity Biotech Fellowship and explores the intersection of AI and bioengineering with cryonics. He contrasts rapid advancements in replacement technologies with the slower progress in cryonics. Rebecca Ziegler discusses public persuasion strategies, emphasizing the importance of framing cryonics as hibernation rather than death. Together, they delve into organ preservation as an investment strategy, debating its potential to convince the public about cryonics.
AI Snips
Chapters
Books
Transcript
Episode notes
Longevity Fellowship Momentum
- Longevity fellowship events accelerate cross-disciplinary progress by connecting ambitious people from varied backgrounds to mentors and funders.
- Eric Magro sees AI and bioengineering advances there but warns cryonics needs more sustained resources and effort.
AI Helps But Cryonics Lags
- AI will help bioengineering but there are still bottlenecks and lots of data to collect before solving aging.
- Cryonics historically lacks resources and manpower, so progress will be slower without new investment.
Organ Preservation vs. Whole-Body Cryonics
- Organ preservation attracts investment because it targets an existing market with clear customers and near-term applications.
- Rebecca doubts that organ preservation directly translates to whole-body cryopreservation science, calling it a different problem.
